We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu
Trial record 21 of 204 for:    Oral Cancer | Recruiting Studies | NIH

Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Previously Treated With Enzalutamide, Androgen Receptor Positive Triple-Negative Breast Cancer Patients, and Men With ER Positive Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02130700
Recruitment Status : Recruiting
First Posted : May 5, 2014
Last Update Posted : March 3, 2017
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Innocrin Pharmaceutical

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : September 2017
  Estimated Study Completion Date : November 2017